Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (ACCD)
NASDAQ:ACCD
Accolade (ACCD) Stock Price & Analysis
341 Followers
ACCD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.33 - $15.36
Previous Close$7.89
Volume818.16K
Average Volume (3M)625.56K
Market Cap
$624.68M
Enterprise Value$614.92M
Total Cash (Recent Filing)$237.03M
Total Debt (Recent Filing)$241.21M
Price to Earnings (P/E)-5.9
Beta2.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.33
Shares Outstanding77,407,607
10 Day Avg. Volume830,404
30 Day Avg. Volume625,558
Standard Deviation0.22
R-Squared0.22
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-33.89
Price to Sales (P/S)4.89
Price to Cash Flow (P/CF)29.30
P/FCF Ratio102.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.48
Enterprise Value/Gross Profit3.20
Enterprise Value/Ebitda-12.76
Forecast
1Y Price Target
$13.38Price Target Upside65.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Accolade News
PremiumCompany Announcements
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
Bulls Say, Bears Say
Bulls Say
Client AcquisitionThe addition of Arkansas Blue Cross Blue Shield as a client demonstrates Accolade's momentum in the health plan market.
Financial PerformanceAccolade outperformed estimates with strong financial performance, indicating robust quarterly results.
Growth And ProfitabilityAccolade's focus on profitable growth is evident with the increase in adjusted EBITDA guidance, reflecting improved financial outlook.
Bears Say
Customer RetentionGross Dollar Retention at 89% fell short of expectations, which partly explains why the actual ACV did not meet projections.
Financial Performance1QFY'25 revenue and adj-EBITDA came in below estimates, which may concern some investors.
GuidanceFY25 revenue growth guidance has been revised down from ~20% to 18.5% year-over-year.
---
Ownership Overview
29.58% Insiders
20.61% Mutual Funds
29.43% Other Institutional Investors
20.39% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACCD FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was $6.33 and its highest was $15.36 in the past 12 months.
What is Accolade’s market cap?
Currently, no data Available
When is Accolade’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Accolade’s earnings last quarter?
Currently, no data Available
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Accolade have?
Accolade has 77,407,610 shares outstanding.
What happened to Accolade’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Accolade?
Among the largest hedge funds holding Accolade’s share is ARK Investment Management LLC. It holds Accolade’s shares valued at 82M.
---
Accolade Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.38 (65.80% Upside)
$13.38 (65.80% Upside)
Blogger Sentiment
Bullish
ACCD Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 182.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.68%
12-Months-Change
Fundamentals
Return on Equity
-21.71%
Trailing 12-Months
Asset Growth
-12.73%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
ACCD Stock 12 Months Forecast
Average Price Target
$13.38
▲(65.80% Upside)
Technical Analysis
Aclaris Therapeutics
―
Acadia Healthcare
―
Achieve Life Sciences
―
ACADIA Pharmaceuticals
―
Best Analysts Covering ACCD
1 Year
1 Year Success Rate
5/17 ratings generated profit
1 Year Average Return
-12.54%
reiterated a buy rating 4 days ago
Copying Ryan MacDonald's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -12.54% per trade.
---